NO990497L - Modifiserte oligosakkarider - Google Patents

Modifiserte oligosakkarider

Info

Publication number
NO990497L
NO990497L NO990497A NO990497A NO990497L NO 990497 L NO990497 L NO 990497L NO 990497 A NO990497 A NO 990497A NO 990497 A NO990497 A NO 990497A NO 990497 L NO990497 L NO 990497L
Authority
NO
Norway
Prior art keywords
modified oligosaccharides
natural
oligosaccharides
modified
sialyl
Prior art date
Application number
NO990497A
Other languages
English (en)
Other versions
NO990497D0 (no
Inventor
Gebhard Thoma
Rolf Bonteli
Willy Kinzy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO990497D0 publication Critical patent/NO990497D0/no
Publication of NO990497L publication Critical patent/NO990497L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Abstract

Derivater av sialyl-Lewis X og A, hvor den naturlige neuraminsyreresten og den naturlige N-acetylglukosaminmonomeren er byttet ut.
NO990497A 1996-08-08 1999-02-03 Modifiserte oligosakkarider NO990497L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96810527 1996-08-08
EP96810526 1996-08-08
EP96810636 1996-09-26
PCT/EP1997/004279 WO1998006730A1 (en) 1996-08-08 1997-08-06 Modified oligosaccharides

Publications (2)

Publication Number Publication Date
NO990497D0 NO990497D0 (no) 1999-02-03
NO990497L true NO990497L (no) 1999-03-24

Family

ID=27237868

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990497A NO990497L (no) 1996-08-08 1999-02-03 Modifiserte oligosakkarider

Country Status (19)

Country Link
EP (1) EP0920437A1 (no)
JP (1) JP2000516224A (no)
KR (1) KR20000029862A (no)
CN (1) CN1227563A (no)
AR (1) AR008283A1 (no)
AU (1) AU720381B2 (no)
BR (1) BR9711117A (no)
CA (1) CA2260854A1 (no)
CO (1) CO4900075A1 (no)
CZ (1) CZ39099A3 (no)
ID (1) ID18010A (no)
IL (1) IL127908A0 (no)
NO (1) NO990497L (no)
NZ (1) NZ334048A (no)
PE (1) PE99298A1 (no)
PL (1) PL331286A1 (no)
SK (1) SK15699A3 (no)
TR (1) TR199900245T2 (no)
WO (1) WO1998006730A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
WO2000044367A2 (en) 1999-02-01 2000-08-03 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
WO2004033473A1 (en) 2002-10-11 2004-04-22 Yamanouchi Europe B.V. Glucose-based compounds with affinity to p-selectin
CA2546784A1 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
PT1934236E (pt) 2005-09-02 2012-12-26 Glycomimetics Inc Inibidores de pan-selectina heterobifuncionais
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
AU2008336249B2 (en) 2007-12-10 2015-01-29 The University Of Queensland Treatment and prophylaxis
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
PL2794626T6 (pl) 2011-12-22 2020-11-02 Glycomimetics, Inc. Związki antagonistyczne E-selektyny
EP2928476B1 (en) 2012-12-07 2018-02-14 GlycoMimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
CA3037850A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
CN108299525B (zh) * 2018-01-05 2021-03-26 佛山科学技术学院 路易斯寡糖-x的合成方法
CA3091454A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN109762032A (zh) * 2019-01-16 2019-05-17 天津科技大学 一种磺酸化路易斯x三糖及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2157489A1 (en) * 1993-03-04 1994-09-15 Masaaki Numata Lewis-associated compound, process for producing the same, and anti-inflammatory
EP0698031A4 (en) * 1993-05-14 1997-07-09 Cytel Corp SIALYL LEx ANALOGS AS INHIBITORS OF CELLULAR ADHESION
CN1176644A (zh) * 1994-12-28 1998-03-18 住友制药株式会社 路易斯x衍生物及其制备方法

Also Published As

Publication number Publication date
ID18010A (id) 1998-02-19
TR199900245T2 (xx) 1999-05-21
IL127908A0 (en) 1999-11-30
AR008283A1 (es) 1999-12-29
WO1998006730A1 (en) 1998-02-19
PL331286A1 (en) 1999-07-05
BR9711117A (pt) 1999-09-08
CZ39099A3 (cs) 1999-05-12
PE99298A1 (es) 1999-01-21
NZ334048A (en) 2000-05-26
AU4378897A (en) 1998-03-06
JP2000516224A (ja) 2000-12-05
KR20000029862A (ko) 2000-05-25
AU720381B2 (en) 2000-06-01
CO4900075A1 (es) 2000-03-27
CA2260854A1 (en) 1998-02-19
SK15699A3 (en) 1999-07-12
NO990497D0 (no) 1999-02-03
CN1227563A (zh) 1999-09-01
EP0920437A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
NO990497L (no) Modifiserte oligosakkarider
AU5062299A (en) Formulations of anionic polysaccharides
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
HU9300486D0 (en) Hydroxi-urea derivatives
TW325547B (en) Modular bus with single or double parallel termination
AU1444697A (en) Sialyl-lewisa and sialyl-lewisx epitope analogues
NZ332345A (en) Thermostable xylanases isolated from Microtetraspora
MX9709146A (es) Compuestos novedosos, preparacion y uso de los mismos.
GR3023436T3 (en) Water insoluble derivatives of hyaluronic acid
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
MY120511A (en) New pesticides
AU1121700A (en) Generating a nonlinear model and generating drive signals for simulation testingusing the same
NO931297L (no) Alginat-oligosakkarid, og framgangsmaate for framstilling av samme
IT9022341A0 (it) Estratti da tessuti animali, utili in terapia e in diagnostica.
MX9703372A (es) Composiciones polimericas claras opticamente que contienen un interpenetrante.
EP0858262A4 (en) THROMBIN INHIBITORS
TR200001745T2 (tr) Keton peroksit türevleri, bunların hazırlanması ve kullanılması
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
EP0820278A4 (en) NON-IMMUNOGENIC BIOCOMPATIBLE MACROMOLECULAR MENBRANE COMPOSITIONS AND METHOD FOR THE PRODUCTION AND USE THEREOF
IL126425A0 (en) Carbohydrate derivatives and their solid-phase synthesis
BR9106554A (pt) Processo de aumentar o efeito de uma polissacarideo hidrolase,processo enzimatico que usa uma polissacarideo hidrolase,preparacao de polissacarideo hidrolase,preparacao de endo-glucanase,preparacao de pululanase mista,preparacao de pululanase mista,e,composicao detergente
EP1143917A3 (en) Anticonvulsant derivatives useful in treating post traumatic stress disorder
EP0632580A3 (de) Verstärkerausgangsstufe.
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application